Emphysematous gastritis is a rare, often fatal disease characterized by the presence of gas within the walls of the stomach and diffuse gastric wall inflammation due to gas-forming bacteria. Gastric mucormycosis is a rare manifestation of invasive fungal disease, ranging from colonization of peptic ulcers to infiltrative disease with vascular invasion and dissemination. The combination of the two conditions is rare. There are a few reports in the literature of invasive gastric mucormycosis associated with emphysematous gastritis that were fatal. Here, we present a case of invasive gastric mucormycosis associated with emphysematous gastritis for which medical management was successful.
Introduction
Emphysematous gastritis is an often fatal, rare clinical entity consisting of gastric wall inflammation, systemic toxicity, and the radiological appearance of air bubbles in the stomach walls secondary to gas production by bacteria. Predisposing factors include ingestion of corrosive substances, alcohol abuse, recent abdominal surgery or gastroenteritis [1] . Prognosis is grave, with a reported mortality rate of 61%, which has remained constant since the earliest reports [2] . Mucormycosis is a term used for infections caused by molds of the order Mucorales. Certain conditions predispose to tissue invasion by these saprophytic fungi, including diabetes mellitus, metabolic acidosis, leukemia, lymphoma, corticosteroid therapy, severe malnutrition, organ transplantation, extensive burns, uremia, deferoxamine-based therapy, use of contaminated bandages and tongue depressors [3, 4] . Mucormycosis is usually an acute, fulminant infection characterized pathologically by the invasion of major blood vessels, with resultant ischemia and infarction of adjacent tissue. Mixed infections with other fungi and bacteria are common. A recent review reported in the literature showed only 10 survivors out of 50 primary gastric mucormycosis cases [5] .
Isolation of fungi from cases of emphysematous gastritis has been rare. Until now, there have been only a few reports of gastric mucormycosis associated with emphysematous gastritis found in the literature, and the results were fatal [6, 7] . Here, we present a case of invasive gastric mucormycosis associated with emphysematous gastritis for which medical management was successful.
Case report
A 57-year-old man presented to our emergency department with fever, shortness of breath, and right upper quadrant pain. He had medical comorbidities of chronic hepatitis B and chronic obstructive pulmonary disease with irregular steroid use. On admission, the laboratory data were: AST, 13,348 IU/L (< 41 IU/L); ALT, 7701 IU/L (< 41 IU/L); total bilirubin, 2.6 mg/dL (< 1.2 mg/dL); blood urea nitrogen, 83 mg/ dL (< 20 mg/dL); creatinine, 5.5 mg/dL (< 1.2 mg/dL); white cell count, 26,590/μL (< 9600/μL); fibrin degradation product, 28.8 μg/mL (< 5 μg/mL); and D-dimer, 9126 ng/mL (< 500 ng/mL). Septic shock with multiorgan failure, involving liver, kidney, lung and coagulopathy was diagnosed. He was intubated for ventilation support. Intravenous penicillin G 3 MU every 6 hours, levofloxacin 250 mg every other day, and cefepime 1000 mg/day were used empirically. The antibiotics were shifted to intravenous meropenem 1000 mg every 12 hours and vancomycin 1000 mg every other day because of the persistent critical condition. Blood cultures showed no growth of bacteria or fungus. Ventilator-associated pneumonia occurred later. Sputum cultures grew Staphylococcus aureus and Hemophillus influenzae.
On day 12 of admission, we found coffee-ground substance in the nasogastric tube. Esophago gastroduodenoscopy revealed a 6 × 7-cm round ulcer with a brown-greenish coating on the base over the greater curvature of the body (Fig. 1 ). Histology disclosed an ulcer with exudates, granulation tissue and fibrin deposits. No Helicobacter pylori was found. Under hematoxylin and eosin staining (400×, Fig. 2A ) and Grocott's methenamine silver staining (400×, Fig. 2B ), many proliferating, nonseptate fungal hyphae with right angle branching were detected that were morphologically consistent with mucormycosis. In addition, he had sphenoid sinusitis but no mucormyces was isolated from nasal sinus fluid.
Contrast-enhanced computed tomography of the abdomen showed a collection of intramural gas over the greater curvature side of the gastric body ( Fig. 3) . Surgical intervention was not performed due to the patient's poor medical condition. A 21-day course of intravenous liposomal amphotericin B was administered intravenously at a dose of 200 mg/day. The patient had a gradual recovery. Follow-up liver function showed rapid return to normal levels, which implied that the acute hepatitis was due to shock. Renal function had deteriorated to creatinine 10.0 mg/dL on the 9th day of admission, then gradually improved to normal levels 1 month after admission. The gastric ulcer healed 1 month after the episode, which was documented by esophagogastroduodenoscopy. The patient remained well during the 11-month follow-up period.
Discussion
Emphysematous gastritis is a rare fatal disorder. In patients with emphysematous gastritis, broad-spectrum antibiotics for Gram-negative rods and anaerobes should be administered. Indications for surgical intervention include perforation, necrosis, ischemia, or failure of conservative management [2, 8] .
The most frequent sites of mucormycosis are the lungs (81%), central nervous system (27%), sinuses (16%), liver (16%) and orbital space (10%) [9] . The gastrointestinal tract was involved in only 7% of cases [10] . The most common gastrointestinal organ affected is the stomach (67%), followed by the colon (21%), small intestine (4%), and esophagus (2%) [10] . Abdominal pain and bloody diarrhea are two typical manifestations. Predisposing factors for invasive gastric mucormycosis include malnutrition, renal insufficiency, im munosuppression, other infections, antibiotic use, and diabetes [10] . In our case, the patient suffered from chronic obstructive pulmonary disease with steroid use that rendered the patient susceptible to Mucorales infection. Furthermore, the most commonly associated condition is the presence of a preexisting gastric ulcer [11] . It is possible that the denuded gastric ulcer base in a compromised host allows the bacteria and fungi to invade deeply, leading to gastric wall necrosis and intramural gas production.
Definitive diagnosis of mucormycosis requires histopathologic evidence of fungal invasion of tissues [3] . The direct detection of fungus in tissues was significantly more sensitive than in cultures [12] . Mucorales readily stains with periodic acid-Schiff, methenamine silver, and routine hematoxylin and eosin stains [4] . Histopathologic sections show broad (3-25 mm in diameter), thin-walled, mostly aseptate hyphae. Frequently, these hyphae show focal bulbous dilation and nondichotomous, irregular branching that occasionally occurs at right angles [3] .
Making recommendations for treatment of gastric mucormycosis is difficult because it is a rare condition and is usually associated with a fatal outcome. The therapy of mucormycosis includes surgical debridement of all necrotic tissue, amphotericin B treatment, and aggressive metabolic support [13] . Because mucormycosis is a highly angioinvasive infection with resulting extensive thrombosis and tissue necrosis, antifungal agents often display poor penetration at the site of the infection. Early surgical debridement of the infected tissue should be performed before the infection disseminates to other organs [3] . The mortality rate was 55% in patients who received antifungal agents alone versus 27% in patients who received antifungal agents and underwent surgery for pulmonary mucormycosis [14] . In our case, however, only medical treatment was given due to his poor medical condition, yet the patient survived.
In conclusion, we present a rare case of a patient who manifested a combination of emphysematous gastritis and gastric mucormycosis. The patient was successfully managed using intensive medical therapy.
